We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sol Schulman

Sol Schulman MD, PhD

Physician-Scientist, Divisions of Hemostasis/Thrombosis and Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, NA
Dr. Sol Schulman is a physician-scientist in the Divisions of Hemostasis/Thrombosis and Hematology/Oncology at the Beth Israel Deaconess Medical Center and Harvard Medical School.  After receiving B.S. and M.S. degrees in biochemistry from Brandeis University, he earned his M.D. and Ph.D. degrees in the joint Harvard – MIT Medical Scientist Training Program.  Dr. Schulman’s thesis research provided important insights into human vitamin K metabolism and the mechanisms of warfarin resistance.  He subsequently completed internal medicine residency training at the Brigham and Women’s Hospital, prior to fellowship training in hematology/oncology at Beth Israel Deaconess Medical Center. 

Dr. Schulman’s clinical practice and research are focused on disorders of hemostasis and thrombosis.  His research integrates human genetics, functional genomics, and protein biochemistry to improve the molecular understanding, diagnosis, and treatment of these disorders.

Disclosures

No disclosures to report.

Recent Contributions to PracticeUpdate:

  1. Outbreak of Synthetic Cannabinoid–Associated Coagulopathy